|
| Exchange Disseminated Time | Aventis Pharma Ltd has informed BSE that the members at the Annual General Meeting (AGM) of the Company held on April 26, 2011, inter alia, have accorded to the following:
1. Adoption of the Accounts for the year ended December 31, 2010 being the Balance Sheet as at December 31, 2010 and the Profit and Loss Account for the year ended on that date with the Auditors’ Report and the Report of the Directors.
2. Approved and confirmed an Interim Dividend for the year ended December 31, 2010 of Rs. 4 per Equity Share of Rs. 10.
- To pay a Final Dividend for the year ended December 31, 2010 of Rs. 23 per Equity Share of Rs. 10 together with a Special One-time Dividend of Rs. 28 per Equity Share of Rs. 10.
3. Re-appointed Mr. S. R. Gupte as a Director.
4. Appointed M/s. S. R. Batliboi & Co., Chartered Accountants, as Auditors of the Company to hold office from the conclusion of this Meeting till the conclusion of the next Annual General Meeting.
5. Appointed Mr. J. M. Georges & Mr. F. X. Duhalde as Directors of the Company.
6. Re-appointment of Dr. S. Ayyangar as Managing Director of the Company for a period of five years with effect from October 25, 2010 on remuneration, terms & conditions.
7. Appointment of Mr. M. U. Rao (presently Alternate to Mr. J. M. Georges) as Whole time Director of the Company for the period from October 25, 2010 to September 05, 2011 on remuneration, terms & conditions. |
|
|